Cargando…

Clinical Pharmacology and Translational Aspects of Bispecific Antibodies

Detalles Bibliográficos
Autores principales:	Trivedi, A, Stienen, S, Zhu, M, Li, H, Yuraszeck, T, Gibbs, J, Heath, T, Loberg, R, Kasichayanula, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421745/ https://www.ncbi.nlm.nih.gov/pubmed/28297195 http://dx.doi.org/10.1111/cts.12459

Ejemplares similares

Translation and Clinical Development of Bispecific T‐cell Engaging Antibodies for Cancer Treatment
por: Yuraszeck, T, et al.
Publicado: (2017)

Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development
por: Gibbs, John P., et al.
Publicado: (2017)

Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
por: Morrissey, KM, et al.
Publicado: (2016)

Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
por: Betts, Alison, et al.
Publicado: (2020)

Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)

Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone
por: Rotman, Marlous, et al.
Publicado: (2018)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

Quantitative Clinical Pharmacology of T‐Cell Engaging Bispecifics: Current Perspectives and Opportunities
por: Morcos, Peter N., et al.
Publicado: (2020)

Bispecific Antibodies: From Research to Clinical Application
por: Ma, Jiabing, et al.
Publicado: (2021)

Bispecific Antibodies for Diagnostic Applications
por: Parashar, Archana, et al.
Publicado: (2011)

Design and Production of Bispecific Antibodies
por: Wang, Qiong, et al.
Publicado: (2019)

Bispecific Antibodies and Gene Therapy
por: Nettelbeck, Dirk M.
Publicado: (2011)

Production of Native Bispecific Antibodies in Rabbits
por: Wang, Wei, et al.
Publicado: (2010)

Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody
por: Schick, Arthur J., et al.
Publicado: (2022)

Evolution of preclinical characterization and insights into clinical pharmacology of checkpoint inhibitors approved for cancer immunotherapy
por: Kasichayanula, Sreeneeranj, et al.
Publicado: (2022)

Tethered-variable C(L) bispecific IgG: an antibody platform for rapid bispecific antibody screening
por: Kim, Hok Seon, et al.
Publicado: (2017)

Quantification of cell surface proteins with bispecific antibodies
por: Panke, C., et al.
Publicado: (2013)

Bispecific antibodies: design, therapy, perspectives
por: Sedykh, Sergey E, et al.
Publicado: (2018)

Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
por: Husain, Bushra, et al.
Publicado: (2018)

Bispecific Antibodies in the Treatment of Hematologic Malignancies
por: Duell, Johannes, et al.
Publicado: (2019)

Bispecific Antibodies Progression in Malignant Melanoma
por: Tang, Juan, et al.
Publicado: (2022)

Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
por: Blanco, Belén, et al.
Publicado: (2021)

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020)

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
por: Antonarelli, Gabriele, et al.
Publicado: (2021)

Rational selection of building blocks for the assembly of bispecific antibodies
por: Gong, Danyang, et al.
Publicado: (2021)

Recent advances and challenges of bispecific antibodies in solid tumors
por: Wu, Yuze, et al.
Publicado: (2021)

Bispecific antibodies come to the aid of cancer immunotherapy
por: Amelio, Ivano, et al.
Publicado: (2021)

Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.
por: Kroesen, B. J., et al.
Publicado: (1996)

Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications
por: Zhu, Yong, et al.
Publicado: (2020)

The state of the art of bispecific antibodies for treating human malignancies
por: Wang, Shuhang, et al.
Publicado: (2021)

Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
por: Bosslet, K., et al.
Publicado: (1991)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Enhanced antigen immunogenicity induced by bispecific antibodies
Publicado: (1990)

Nanocell targeting using engineered bispecific antibodies
por: Taylor, Karin, et al.
Publicado: (2014)

Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2020)

Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
por: Register, Ames C., et al.
Publicado: (2021)

Immunotherapeutic progress and application of bispecific antibody in cancer
por: Kang, Jingyue, et al.
Publicado: (2022)

Bispecific Antibodies in Hematological Malignancies: A Scoping Review
por: Omer, Mohamed H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ua7j49n70v2f1g8um38hi1auhk